Should I invest in UTI Medium Duration Fund - Monthly IDCW?

We don't give personal investment advice. UTI Medium Duration Fund - Regular Plan - Monthly IDCW is suitable for an investor whose:time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ yearsprimary goal is capital preservation or steady accrual, not high growthtax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 1.8%. 5-year CAGR: 5.84%.

UTI

UTI Medium Duration Fund - Regular Plan - Monthly IDCW

Latest NAV

₹13.5713

As of

3 Jun 2026

2,696 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.05%	+76.20%	-76.15	15 / 19	Q4
1W	+0.10%	+41.40%	-41.31	15 / 23	Q3
2W	+0.31%	+81.02%	-80.71	13 / 18	Q3
1M	+0.11%	+81.50%	-81.39	15 / 18	Q4
3M	+0.05%	+87.43%	-87.38	9 / 17	Q3
6M	+0.98%	+84.56%	-83.59	9 / 18	Q2
YTD	+0.84%	+75.65%	-74.82	9 / 19	Q2
1Y	+2.70%	+91.60%	-88.90	10 / 18	Q3
2Y	+5.84%	+25.99%	-20.15	10 / 18	Q3
3Y	+5.96%	+2.01%	+3.95	5 / 13	Q2
4Y	+6.19%	+3.25%	+2.93	4 / 11	Q2
5Y	+5.84%	+2.51%	+3.33	2 / 11	Q1
7Y	+4.28%	+1.67%	+2.61	1 / 9	Q1
10Y	+2.85%	+1.31%	+1.54	3 / 8	Q2
Inception	+2.77%	-0.76%	+3.53	10 / 24	Q2

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	+0.84%	-2.57%	+3.40	2 / 12
2025	+6.50%	+3.45%	+3.05	6 / 13
2024	+7.62%	+3.67%	+3.95	4 / 12
2023	+6.37%	+2.86%	+3.50	3 / 12
2022	+2.42%	+91.44%	-89.02	7 / 16
2021	+6.11%	-4.67%	+10.77	2 / 14
2020	-1.01%	-1.67%	+0.66	7 / 9
2019	+0.09%	+2.25%	-2.15	8 / 9
2018	-1.45%	+0.61%	-2.06	7 / 9
2017	-1.50%	-0.15%	-1.35	6 / 8
2016	+0.69%	+2.02%	-1.33	7 / 7

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+2.67%

124 windows

min -4.4% · max 9.3%

71% positive

3-Year rolling

+2.41%

100 windows

min -2.1% · max 7.4%

64% positive

5-Year rolling

+2.28%

76 windows

min -1.0% · max 6.2%

76% positive

7-Year rolling

+2.29%

51 windows

min 0.6% · max 4.3%

100% positive

Limited basis — fund is young, so this average may be skewed by which 7Y windows happen to be available.

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

1.54%

3-year · annualised

Sharpe ratio

-0.45

vs risk-free 6.5%

Sortino ratio

-1.18

Downside-only deviation

Max drawdown

-1.03%

Mar 2026 → Apr 2026

% positive months

91.7%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Medium Duration Fund

Scheme	Fund house	NAV	As of
Invesco India Medium Duration Fund - Regular Plan - Discretionary IDCW(Payout / Reinvestment))	Invesco	₹1,273.0112	3 Jun 2026
Bandhan Medium Duration Fund - Regular Plan - Periodic IDCW	Bandhan	₹14.9026	3 Jun 2026
HSBC Medium Duration Fund - Regular Annual IDCW	HSBC	₹10.3826	3 Jun 2026
UTI - Medium Term Fund (Segregated - 06032020) - Regular Plan - Annual Dividend Option	UTI	₹0.0000	3 Jun 2026
Axis Strategic Bond Fund - Regular Plan - Half Yearly IDCW	Axis	₹10.3409	3 Jun 2026

Recent NAVs

Date	NAV
3 Jun 2026	₹13.5713
2 Jun 2026	₹13.5744
1 Jun 2026	₹13.5680
29 May 2026	₹13.5688
27 May 2026	₹13.5609
26 May 2026	₹13.5612
25 May 2026	₹13.5544
22 May 2026	₹13.5352
21 May 2026	₹13.5230
20 May 2026	₹13.5315

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 03 Jun 2026, the NAV of UTI Medium Duration Fund - Regular Plan - Monthly IDCW is ₹13.5713. It's a Medium Duration Fund from UTI, run as a Regular plan IDCW (dividend) option. NAVs update once per business day from the AMFI feed.

UTI Medium Duration Fund - Regular Plan - Monthly IDCW has NAV history starting from 09 Apr 2015, a track record of about 11 years 1 months. That's enough history to evaluate the fund across one or two market cycles. Look at rolling returns rather than point-to-point to judge consistency.

UTI Medium Duration Fund - Regular Plan - Monthly IDCW is managed by UTI. It's classified by AMFI under the 'Medium Duration Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI Medium Duration Fund - Regular Plan - Monthly IDCW has delivered a absolute return of 2.70% — -88.9 pp behind the Medium Duration Fund category average of 91.60%. The fund ranks #10 of 18 in its category — the third (Q3) quartile.

Over the trailing 3-year window, UTI Medium Duration Fund - Regular Plan - Monthly IDCW has delivered a CAGR of 5.96% — +3.95 pp ahead of the Medium Duration Fund category average of 2.01%. The fund ranks #5 of 13 in its category — the second (Q2) quartile.

Over the trailing 5-year window, UTI Medium Duration Fund - Regular Plan - Monthly IDCW has delivered a CAGR of 5.84% — +3.33 pp ahead of the Medium Duration Fund category average of 2.51%. The fund ranks #2 of 11 in its category — the top (Q1) quartile.

₹1 lakh invested in UTI Medium Duration Fund - Regular Plan - Monthly IDCW exactly 10 years ago would be worth approximately ₹132,463 today — a multiplier of 1.32×, based on the 10-year CAGR of 2.85%. The category average over the same window would have grown ₹1 lakh to ₹113,891.

A ₹10,000 monthly SIP in UTI Medium Duration Fund - Regular Plan - Monthly IDCW over the last 5 years — total invested ₹600,000 — would be worth ₹693,430 today. That's an XIRR (money-weighted annualised return) of 5.72%.

A ₹10,000 monthly SIP for 10 years in UTI Medium Duration Fund - Regular Plan - Monthly IDCW = ₹1,200,000 invested. It would currently be worth ₹1,487,979 (multiplier 1.24×). XIRR: 4.21%. Long-horizon SIP results matter more than point-to-point returns because they smooth out entry timing.

On a 5-year basis, UTI Medium Duration Fund - Regular Plan - Monthly IDCW ranks #2 out of 11 funds in the Medium Duration Fund category — that places it in the top quartile (Q1) — strong outperformance. The category average return over the same window is 2.51%; this fund delivered 5.84%.

The worst peak-to-trough decline UTI Medium Duration Fund - Regular Plan - Monthly IDCW has experienced over the last 5-year window is 1.82% — its NAV fell from a high on 30 Mar 2022 to a low on 09 May 2022. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, UTI Medium Duration Fund - Regular Plan - Monthly IDCW averaged 2.28% (best 6.19%, worst -0.96%). 76% of rolling windows ended positive. The 5-year Sharpe ratio is -0.38 — negative risk-adjusted performance.

In calendar year 2025, UTI Medium Duration Fund - Regular Plan - Monthly IDCW returned 6.50% — beating the Medium Duration Fund category average of 3.45% by 3.05 pp. It ranked #6 of 13 in its category that year.

UTI Medium Duration Fund - Regular Plan - Monthly IDCW is classified as a Debt fund. For units acquired on or after 1 April 2023, all gains are taxed at your income-tax slab rate regardless of holding period — there's no LTCG concession or indexation. For pre-April-2023 units, the old rules with indexation still apply on long-term gains.

We don't give personal investment advice. UTI Medium Duration Fund - Regular Plan - Monthly IDCW is suitable for an investor whose:

time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ years
primary goal is capital preservation or steady accrual, not high growth
tax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 1.8%. 5-year CAGR: 5.84%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.